These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4082545)

  • 1. [Use of a Soviet preparation of rifampicin for intravenous injection in the treatment of patients with destructive tuberculosis of the lungs].
    Ivaniuta OM; Panasiuk AV; Il'nitskiĭ IG; Davyda RS; Kunichkina SA
    Vrach Delo; 1985 Nov; (11):32-4. PubMed ID: 4082545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin].
    Reĭle EE; Polushkina EE
    Probl Tuberk; 1987; (2):22-5. PubMed ID: 3575271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; von Sassen W; Labedzki L; Schwabe HK; Hengstmann J; Eichelbaum M
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():482-4. PubMed ID: 6647280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis].
    Chernushenko EF; Kogosova LS; Il'nitskiĭ IG; Petrashenko AI; Goncharova SI
    Probl Tuberk; 1989; (7):39-43. PubMed ID: 2798385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN; Vorob'ev VS; Khoron'ko VV; Anisimova NB; Chubarian VT
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Corrective possibilities of rifampicin in ineffective chemotherapy of destructive pulmonary tuberculosis in children and adolescents].
    Ivaniuta OM; Il'nitskiĭ IG; Panasiuk AV; Kunichkina SA
    Probl Tuberk; 1987; (8):30-3. PubMed ID: 3684986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of rifampicin in venous perfusion in a group of patients with pulmonary tuberculosis].
    Bettini L; Fossati C
    Clin Ter; 1976 Nov; 79(3):263-72. PubMed ID: 1017171
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Soviet-made rifampicin in pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Kolesnikova ZhIa; Petrash OV
    Vrach Delo; 1978 Oct; (10):52-6. PubMed ID: 716359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
    Jungbluth H
    Prax Klin Pneumol; 1984 May; 38(5):177-81. PubMed ID: 6379634
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment].
    Yamamoto M; Isoe K; Nakamura H; Hirose H; Izumi S
    Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M; Tuchais E; Viallet S; Chauvet G
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical use of rifampicin in tuberculosis].
    Giuliano V
    G Ital Mal Torace; 1969; ():Suppl 2:50-9. PubMed ID: 5357139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.